Gracell US shares – listed on the Nasdaq – were up more than 60% at the time of writing.
AstraZeneca (NASDAQ:AZN) has announced plans to acquire biotechnology company EsoBiotec for up to $1 billion, aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback